Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

You are viewing the site in preview mode

Skip to main content

Table 1 Baseline characteristics of the included patients

From: Optimizing outcomes in acute pancreatitis: the impact of of heparin therapy duration on mortality in a multi-center retrospective study

 

Groups

All

1st-25th

(< 4 days)

26th-50th

(4–7 days)

51th-75th

(8–14 days)

75th-100th

(> 14 days)

P

No of patients

1705

280

596

424

405

 

Gender

     

0.282

Male

990(58.06)

160(57.14)

339(56.88)

239(56.37)

252(62.22)

 

Female

715(41.94)

120(42.86)

257(43.12)

185(43.63)

153(37.78)

 

Age

60.88±16.98

63.04±16.80

62.39±17.42

60.50±16.78

57.57±16.21

< 0.001

BMI

28.46±7.61

28.49±6.38

27.83±9.00

29.09±7.22

28.70±6.41

0.060

Etiologies

      

Gallstones

588(34.49)

108(38.57)

205(34.40)

168(39.62)

107(26.42)

< 0.001

Alcohol

471(27.62)

71(25.36)

164(27.52)

125(29.48)

111(27.41)

0.691

Hypertriglyceridemia

172(10.09)

26(9.29)

72(12.08)

31(7.31)

43(10.62)

0.088

Post-ERCP/EUS

113(6.63)

13(4.64)

30(5.03)

36(8.49)

34(8.40)

0.034

Pancreatic tumors or cystic lesions

259(15.19)

27(9.64)

69(11.58)

65(15.33)

98(24.20)

< 0.001

Medications

114(6.69)

15(5.36)

20(3.36)

42(9.91)

37(9.14)

< 0.001

Infection

165(9.68)

23(8.21)

31(5.20)

36(8.49)

75(18.52)

< 0.001

CCI score

     

0.905

1 (CCI = 0)

172(10.09)

28(10.00)

52(8.72)

44(10.38)

48(11.85)

 

2 (CCI = 1 or 2)

448(26.28)

67(23.93)

163(27.32)

113(26.65)

105(25.94)

 

3 (CCI = 3 or 4)

433(25.40)

79(28.21)

147(24.66)

101(23.82)

106(26.17)

 

4 (CCI = 5 or 6)

329(19.30)

50(17.86)

121(20.30)

85(20.05)

73(18.02)

 

5 (CCI ≥ 7)

323(18.93)

56(20.00)

113(19.00)

81(19.10)

73(18.02)

 

BISAP score

     

< 0.001

1 (BISAP = 0 or 1)

542(31.79)

108 (38.57)

225 (37.75)

132 (31.13)

77 (19.01)

 

2 (BISAP = 2)

608 (35.66)

94 (33.57)

215 (36.08)

138 (32.55)

161 (39.75)

 

3 (BISAP ≥ 3)

555 (32.55)

78 (27.86)

156 (26.17)

154 (36.32)

167 (41.24)

 

Laboratory Examinations

      

BUN (mg/dL)

26.84±23.31

24.13±20.23

24.33±20.39

28.29±25.09

30.88±26.55

< 0.001

WBC (×109/L)

12.51±7.46

10.80±6.41

11.86±7.21

13.00±7.64

14.12±7.93

< 0.001

Hb (g/dL)

11.27±2.29

11.47±2.18

11.35±2.19

11.21±2.23

11.08±2.53

0.100

Cr (mg/dL)

1.71±1.91

1.59±1.55

1.48±1.41

1.91±2.24

1.94±2.33

< 0.001

Hct (%)

31.92±6.02

33.32±5.65

32.87±5.72

31.60±6.11

29.91±6.06

< 0.001

RDW (%)

15.35±2.28

15.11±2.24

15.10±2.10

15.48±2.45

15.75±2.32

< 0.001